Article Details
Retrieved on: 2024-02-07 23:59:48
Tags for this article:
Click the tags to see associated articles and topics
Summary
Alto Neuroscience, a biopharmaceutical company in neuroscience, successfully completed an upsized IPO, involving major financial entities and regulated by the U.S. SEC. Proceeds will support their Precision Psychiatry Platform development.
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here